Cellectis
Founded 1999 · 241 employees on LinkedIn · 1 known investors
Find your way into Cellectis
Sign up to see every warm intro you have to Cellectis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellectis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
Investors · 1
Frequently asked questions
- What does Cellectis do?
- Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
- Who are Cellectis's investors?
- Cellectis's investors include Ridgeback Capital.
